Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities - Accrued Liabilities (Details)

v3.23.1
Note 8 - Accrued Liabilities - Accrued Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Accrued compensation $ 161 $ 667
Accrued clinical trial costs 376 472
Accrued research and other professional fees 414 215
Accrued other liabilities 5 11
Total accrued liabilities $ 956 $ 1,365